Poliovirus vaccination options for achieving eradication and securing the endgame✩

Details

• Alternative Title:
  Curr Opin Virol
• Personal Author:
  Estívariz, Concepción F ; Pallansch, Mark A ; Anand, Abhijeet ; Wassilak, Steven GF ; Sutter, Roland W ; Wenger, Jay D ; Orenstein, Walter A
• Description:
  In 1988, the World Health Assembly resolved to globally eradicate poliomyelitis. As part of a four-pronged strategy with establishment of enhanced surveillance, institution of national immunization days, strengthening routine immunization, and carrying-out mopping-up activities, oral poliovirus vaccine (OPV) was selected as the vaccine-of-choice for eradication. Massive OPV use decreased the number of polio-endemic countries from >125 countries in 1988 to only 3 in 2012 and led to a >99.9% decrease in polio incidence in the corresponding period. In this communication, we will discuss polio vaccination options to accelerate eradication, to mitigate the risks during the planned withdrawal of type 2 OPV, and to secure eradication for future generations.
• Subjects:
  Disease Eradication Endemic Diseases Global Health Humans Incidence Poliomyelitis Poliovirus Vaccine, Oral Vaccination
• Source:
  Curr Opin Virol. 3(3):309-315
• Pubmed ID:
  23759252
• Pubmed Central ID:
  PMC10395005
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Volume:
  3
• Issue:
  3
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:60e18f1ac390d4884be3592e30d45c9d284c61c6671def0a51dccccd79c37b60
• Download URL:
  https://stacks.cdc.gov/view/cdc/131721/cdc_131721_DS1.pdf
• File Type:
  [PDF - 351.52 KB ]